| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005398199 |
| P356 | DOI | 10.1007/S11886-014-0492-5 |
| P698 | PubMed publication ID | 24803385 |
| P50 | author | Harvey White | Q1587897 |
| Kristian Thygesen | Q43407424 | ||
| P2093 | author name string | Joseph S Alpert | |
| Kristian Thygesen | |||
| Allan Jaffe | |||
| P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
| Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study | Q30426457 | ||
| The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: from falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time? | Q33356490 | ||
| Biomarkers in acute cardiac disease: the present and the future | Q33997300 | ||
| Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA | Q34112005 | ||
| Third universal definition of myocardial infarction | Q34295914 | ||
| Effect of platelet inhibition with cangrelor during PCI on ischemic events | Q34331909 | ||
| Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators | Q34371355 | ||
| Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort | Q34549223 | ||
| Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition | Q34962673 | ||
| Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes | Q35088069 | ||
| Chronic hyperglycemia and subclinical myocardial injury | Q35706211 | ||
| The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome | Q36084618 | ||
| A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging: a statement for healthcare professionals from a committee appointed by the Internationa | Q36624282 | ||
| The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome | Q37129419 | ||
| Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. | Q37291917 | ||
| Analytical characteristics of high-sensitivity cardiac troponin assays | Q37941605 | ||
| Patients with circumflex occlusions miss out on reperfusion: how to recognize and manage them | Q38008149 | ||
| Preparing the United States for high-sensitivity cardiac troponin assays | Q38080255 | ||
| Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention | Q38081104 | ||
| Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends | Q38107694 | ||
| Unstable angina: is it time for a requiem? | Q38115155 | ||
| Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary | Q38181728 | ||
| Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes | Q39671364 | ||
| Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients | Q43209440 | ||
| Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease | Q43734054 | ||
| Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality | Q43943833 | ||
| Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations | Q44525987 | ||
| Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury | Q44942020 | ||
| Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous | Q45197922 | ||
| Classification of myocardial infarction: frequency and features of type 2 myocardial infarction | Q45277455 | ||
| Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population | Q45775230 | ||
| Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial | Q45811402 | ||
| Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). | Q45839848 | ||
| Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in My | Q46006836 | ||
| Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years | Q46136203 | ||
| Baseline troponin level: key to understanding the importance of post-PCI troponin elevations | Q46947043 | ||
| The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). | Q46965928 | ||
| Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy | Q48636749 | ||
| Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. | Q50503127 | ||
| Using high-sensitivity troponin T: the importance of the proper gold standard. | Q50910308 | ||
| Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome | Q51070655 | ||
| The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. | Q53483677 | ||
| Acute myocardial infarction | Q54069247 | ||
| Third Universal Definition of Myocardial Infarction | Q56535247 | ||
| Third Universal Definition of Myocardial Infarction | Q56627595 | ||
| Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial | Q57243360 | ||
| Third universal definition of myocardial infarction | Q57314061 | ||
| Redefinition of Myocardial Infarction | Q57540189 | ||
| How to use high-sensitivity cardiac troponins in acute cardiac care | Q58314226 | ||
| Prognostic Usefulness of Circulating High-Sensitivity Troponin T in Aortic Stenosis and Relation to Echocardiographic Indexes of Cardiac Function and Anatomy | Q58867612 | ||
| Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction | Q78251210 | ||
| National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes | Q80032865 | ||
| Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients | Q80525387 | ||
| A new definition for myocardial infarction: what difference does it make? | Q81621643 | ||
| Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding | Q82809037 | ||
| American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TI | Q83134572 | ||
| Why all the struggle about CK-MB and PCI? | Q83221781 | ||
| Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction | Q83279067 | ||
| The prequel: defining prognostically important criteria in the periprocedural PCI troponin saga | Q83916585 | ||
| Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? | Q84318543 | ||
| Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay | Q84947952 | ||
| Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort | Q87153768 | ||
| Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3 | Q93649165 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 492 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Universal MI definition update for cardiovascular disease | |
| P478 | volume | 16 |
| Q92108990 | Decreased atrioventricular plane displacement after acute myocardial infarction yields a concomitant decrease in stroke volume |
| Q47261872 | ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery |
| Q57056940 | Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention |
| Q41416624 | Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction |
| Q30235552 | Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality |
| Q57452741 | Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers |
| Q58778560 | Patient-reported symptoms improve prediction of acute coronary syndrome in the emergency department |
| Q53127767 | Proton pump inhibitors and other disease-based factors in the recurrence of adverse cardiovascular events following percutaneous coronary angiography: A long-term cohort. |
| Q51838993 | Quality Improvement Intervention for Reduction of Redundant Testing. |
| Q59355697 | Telephone-based mindfulness training to reduce stress in women with myocardial infarction: Rationale and design of a multicenter randomized controlled trial |
Search more.